ArticleJournal of thoracic disease2025
Global insights into lung cancer-related depression and anxiety from 2005 to 2025: a bibliometric analysis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression and anxiety are common psychiatric symptoms among lung cancer patients, compromising quality of life. A growing number of reports have explored the relationship between lung cancer and these psychological disorders. This study aimed to evaluate the research trends and emerging hotspots in lung cancer-related depression and anxiety from a bibliometric perspective. Methods: Relevant articles published between 2005 and 2025 were retrieved from Web of Science Core Collection. VOSviewer, CiteSpace, the "bibliometrix" R package, and an online bibliometric analysis platform were employed to examine publication trends and research hotspots. Regression analysis using Microsoft Excel 2021 was conducted to estimate future publication trends. Results: Overall, 289 articles on lung cancer-related depression and anxiety were identified, with most studies focusing on lung cancer as a contributing factor to these conditions. The United States and China emerged as the most prominent contributors regarding international collaboration and publication volume. Harvard University was the leading institution in research output, while Daniel C. McFarland was the most prolific author. Recent research hotspots included fatigue, stress, and non-small cell lung cancer (NSCLC). Conclusions: Future studies should investigate the roles and biological mechanisms of psychological interventions in lung cancer cases with depression or anxiety, particularly in those with NSCLC. This study provides a systematic overview and valuable insights to guide future investigations in this field.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.